Skip to content

menu

Health Law Pulse logo
HomeAboutContact
Search
Close
RegulatoryEnforcementFDA & Food SafetyTransparencyInternational
View topics Archives
Subscribe

Health Law Pulse

Leading insight on legal developments in the healthcare and life sciences industries.

CVS

Subscribe to CVS via RSS

Third and Fifth circuits accept materiality arguments in throwing out qui tam cases

Posted on November 27, 2017

On November 16, 2017, the Third Circuit Court of Appeals affirmed the grant of summary judgment in favor of CVS Caremark, Corp. (“CVS Caremark”), finding that although the lower court’s reasoning was flawed, the whistleblower Anthony Spay failed to establish…

CVS customers denied class certification in lawsuit alleging overcharging for generic prescriptions

Posted on March 22, 2017

On Tuesday, March 21st, the U.S. District Court for the Northern District of California denied class certification in a suit alleging that CVS had overcharged insurance companies for generic prescriptions, resulting in higher copayments for customers. Corcoran, et…

Subscribe to Health Law Pulse

Subscribe to this publication

Challenge dropped to dismissal of allegations of pharmacy-reward fraud

Posted on September 17, 2015

A relator is dropping his appeal of a district court decision that granted a motion to dismiss FCA claims against CVS.  Procedural deficiencies were raised with relator’s appeal, including missing the filing deadline for his appeal in the U.S. Court…

Health Law Pulse

Facebook Twitter RSS LinkedIn YouTube
Published by
Norton Rose Fulbright LLP logo
DisclaimerPrivacy policy

About

Stay up-to-date on healthcare enforcement and regulations with the Health Law Pulse. We give you the news and analysis that matter to your business in a quick, easy-to-read format.

Read more

Topics

Archives

Copyright © 2025, Norton Rose Fulbright LLP. All rights reserved.